Live Quote · AMEXATNMHealthcare· Biotechnology

Actinium Pharmaceuticals, Inc.

$1.05▼ 1.87%($-0.02)
MKT CAP $33.01MNEXT EARNINGS Mar 29, 2027
50%
Bullish
TickerSpark Score
69/100
▌ Solid
97
Valuation
100
Profitability
50
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATNM research report →

Analyst Price Target
$11.07+954.3% vs. today

Range $4 – $24.26

Analyst RatingBuy
11 Buy0 Hold0 Sell

Price Chart

-21.32% · this period
$1.69$1.22$0.75Nov 19May 22Nov 19
52-Week Range32% of range
Low
$0.73
Current
$1.05
High
$1.72